title: Gavin Giovannoni on why time matters in multiple sclerosis.
authors.affiliation: Queen Mary University London, Blizard Institute, Barts & The London School of Medicine & Dentistry, London, UK.
authors.forename: Gavin
authors.initials: G
authors.lastname: Giovannoni
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D017326:Clinical Trials, Phase III as Topic / Q000379:methods; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000175:diagnosis* / Q000188:drug therapy* / Q000276:immunology; D012108:Research Personnel / Q000639:trends; D013997:Time Factors
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; C533411:ocrelizumab
keywords: access; brain health; diagnosis; disease-modifying treatment; innovation